Cargando…
The Clinical Impact of Flow Titration on Epoprostenol Delivery via High Flow Nasal Cannula for ICU Patients with Pulmonary Hypertension or Right Ventricular Dysfunction: A Retrospective Cohort Comparison Study
(1) Background: inhaled epoprostenol (iEPO) delivered via high-flow nasal cannula (HFNC) has been reported to be effective for pulmonary hypertension and right ventricular dysfunction. In vitro studies have identified HFNC gas flow as a key factor in trans-nasal aerosol delivery efficiency; however,...
Autores principales: | Li, Jie, Gurnani, Payal K., Roberts, Keith M., Fink, James B., Vines, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074129/ https://www.ncbi.nlm.nih.gov/pubmed/32046152 http://dx.doi.org/10.3390/jcm9020464 |
Ejemplares similares
-
Epoprostenol Delivered via High Flow Nasal Cannula for ICU Subjects with Severe Hypoxemia Comorbid with Pulmonary Hypertension or Right Heart Dysfunction
por: Li, Jie, et al.
Publicado: (2019) -
High-flow nasal cannula for bronchiolitis in an ICU and step-down unit
por: Genereux, Madeleine M., et al.
Publicado: (2020) -
HIGH-FLOW NASAL CANULA AND INHALED EPOPROSTENOL RESPONSE IN COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2022) -
Flow Wave Interpretation of High-Flow Nasal Cannula
por: Marín, Toni, et al.
Publicado: (2021) -
In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
por: Li, Jie, et al.
Publicado: (2021)